ArticleChildhood kidney diseases2026
Risk factors for chronic kidney disease progression in VACTERL-association Korean patients: a retrospective study.
Article in Childhood kidney diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Renal anomalies account for 50% to 80% of vertebral, anal, cardiac, tracheoesophageal fistula with or without atresia, renal and limb (VACTERL) associations. Some of these patients develop chronic kidney disease (CKD). This study evaluated the clinical characteristics, prevalence, and risk factors of CKD in VACTERL-association patients. Methods: The medical records of pediatric VACTERL-association patients who visited Samsung Medical Center from January 2011 to December 2019 were reviewed retrospectively using a traditional Schwarz formula to estimated glomerular filtration rate by serum creatinine. Cases of CKD were classified according to Kidney Disease Improving Global Outcomes guidelines as stages 2 to 5. Results: A total of 47 VACTERL-association patients were enrolled. Renal anomalies were presented in 89.4% of patients. The mean follow-up period was 3.26 years. Half of the patients had a urinary tract infection, and 83.3% of these experienced more than one. Vesicoureteral reflux was detected in 23 patients. Twenty patients experienced acute kidney injury (AKI). Among them, 20% progressed to CKD. Two AKI patients required kidney replacement therapy. In this study, the prevalence of CKD was 14.9%. Complex renal anomalies and stage 3 AKI increased the risk of CKD progression in patients with VACTERL association by 11-fold and 9-fold, respectively ( Conclusions: Several factors such as complex renal anomalies and stage 3 AKI may influence kidney function in VACTERL association. A further longitudinal study of CKD in VACTERL-association patients is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.